Ralliant (NYSE:RAL) Reaches New 12-Month High – Here’s Why

Ralliant Corporation (NYSE:RAL) shares hit a new 52-week high during mid-day trading on Monday . The company traded as high as $67.01 and last traded at $67.58, with a volume of 1176914 shares traded. The stock had previously closed at $66.08.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Morgan Stanley raised their price target on Ralliant from $45.00 to $68.00 and gave the stock an “overweight” rating in a research report on Thursday, May 14th. TD Cowen raised their price target on Ralliant from $55.00 to $70.00 and gave the stock a “buy” rating in a research report on Wednesday, May 20th. Weiss Ratings restated a “sell (d)” rating on shares of Ralliant in a research report on Monday, May 4th. Evercore started coverage on Ralliant in a research report on Tuesday, June 9th. They issued an “outperform” rating and a $80.00 price target for the company. Finally, Citigroup boosted their price objective on Ralliant from $51.00 to $70.00 and gave the company a “buy” rating in a report on Wednesday, May 13th. Seven analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $67.30.

Ralliant Trading Down 0.0%

The stock has a fifty day moving average of $54.11 and a 200-day moving average of $50.13. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.05 and a current ratio of 1.61. The company has a market cap of $7.70 billion and a PE ratio of -6.28.

Ralliant (NYSE:RAL) last posted its quarterly earnings data on Tuesday, May 12th. The company reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.49 by $0.08. Ralliant had a positive return on equity of 12.49% and a negative net margin of 58.55%.The company had revenue of $534.60 million during the quarter. The business’s quarterly revenue was up 11.0% on a year-over-year basis. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. Sell-side analysts anticipate that Ralliant Corporation will post 2.64 EPS for the current fiscal year.

Ralliant Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 23rd. Investors of record on Monday, June 8th will be issued a dividend of $0.05 per share. The ex-dividend date is Monday, June 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Ralliant’s payout ratio is presently -1.83%.

Hedge Funds Weigh In On Ralliant

A number of large investors have recently bought and sold shares of the business. Danske Bank A S purchased a new stake in shares of Ralliant in the 4th quarter worth $25,000. V Square Quantitative Management LLC purchased a new stake in shares of Ralliant in the 4th quarter worth $26,000. Allworth Financial LP lifted its holdings in shares of Ralliant by 134.4% in the 4th quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after buying an additional 293 shares during the period. Palisade Asset Management LLC purchased a new stake in shares of Ralliant in the 3rd quarter worth $26,000. Finally, BOKF NA purchased a new stake in shares of Ralliant in the 3rd quarter worth $29,000.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.